研究者
J-GLOBAL ID：202101004485547699   更新日: 2023年04月06日

上田 響子

ウエダ キョウコ | UEDA KYOKO
所属機関・部署：
東京慈恵会医科大学付属病院 緩和ケア診療部

東京慈恵会医科大学付属病院 緩和ケア診療部 について


論文 (6件)：
  • Kazuhito Suzuki, Yasuhito Terui, Noriko Nishimura, Kyoko Ueda, Yuko Mishima, Sakura Sakajiri, Masahiro Yokoyama, Keisuke Aiba, Kiyohiko Hatake. Rapid progression of anemia related to tumor-lysis syndrome associated with bortezomib treatment in myeloma patients. Japanese journal of clinical oncology. 2014. 44. 5. 435-41
  • Kyoko Ueda, Yasuhito Terui, Masahiro Yokoyama, Sakura Sakajiri, Noriko Nishimura, Naoko Tsuyama, Kengo Takeuchi, Kiyohiko Hatake. Non-gastric advanced mucosa-associated lymphoid tissue (MALT) lymphoma has worse prognosis than gastric MALT lymphoma even when treated with rituximab-containing chemotherapy. Leukemia & Lymphoma. 2013. 54. 9. 1928-1933
  • Kazuhito Suzuki, Yasuhito Terui, Masahiro Yokoyama, Kyoko Ueda, Noriko Nishimura, Yuko Mishima, Sakura Sakajiri, Naoko Tsuyama, Kengo Takeuchi, Kiyohiko Hatake. Prognostic value of high thymidine kinase activity in patients with previously untreated diffuse large B-cell lymphoma treated by rituximab, cyclophosphamide, doxorubicin, vincristine and prednisolone. Leukemia and Lymphoma. 2013. 54. 11. 2412-2417
  • Yuko Mishima, Yasuhito Terui, Masahiro Yokoyama, Noriko Nishimura, Sakura Sakajiri, Kyoko Ueda, Yasutoshi Kuboki, Kenji Nakano, Kazuhito Suzuki, Eriko Nara, et al. R-CHOP with dose-attenuated radiation therapy could induce good prognosis in gastric diffuse large B cell lymphoma. Experimental hematology & oncology. 2012. 1. 1. 30-30
  • Kazuhito Suzuki, Yasuhito Terui, Kenji Nakano, Eriko Nara, Kentaro Nasu, Kyoko Ueda, Noriko Nishimura, Yuko Mishima, Sakura Sakajiri, Masahiro Yokoyama, et al. High thymidine kinase activity is a strong predictive factor for poor prognosis in peripheral T-cell lymphoma treated with cyclophosphamide, adriamycin, vincristine and prednisone. Leukemia & lymphoma. 2012. 53. 5. 849-54
もっと見る
MISC (2件)：
  • Yuko Mishima, Masahiro Yokoyama, Noriko Nishimura, Kyoko Ueda, Tadahiro Gunji, Hideaki Nitta, Yoshiharu Kusano, Norihito Inoue, Anna Takahashi, Naoko Tsuyama, et al. R-CHOP Therapy Cannot Overcome CD5 Positive Non-GCB Subtype of DLBCL. BLOOD. 2015. 126. 23
  • Yoshiharu Kusano, Yasuhito Terui, Noriko Nishimura, Kyoko Ueda, Gunji Tadahiro, Hideaki Nitta, Yuko Mishima, Masahiro Yokoyama, Naoko Tsuyama, Kengo Takeuchi, et al. ICE (Ifosfamide, carboplatin, and etoposide) Was the Best Salvage Regimen in Patients with Relapsed or Refractory Malignant Lymphoma. BLOOD. 2014. 124. 21
※　J-GLOBALの研究者情報は、researchmapの登録情報に基づき表示しています。 登録・更新については、こちらをご覧ください。

前のページに戻る

TOP

BOTTOM